August 15, 2024
Immunophotonics Announces 1st Patient Dosed in a Randomized Phase 2 Study at the University of Louisville
We are thrilled to announce that Dr. Robert Martin has successfully enrolled and treated the first patient in our groundbreaking...
Read More
August 6, 2024
Professor Wei R. Chen Organizes Immunophotonics Session at Gordan Research Conference
Immunophotonics is excited to share that Wei Chen, co-inventor of IP-001, Stephenson Chair, professor and interim director of the Stephenson...
Read More
July 30, 2024
Immunophotonics featured in Pharma Tech Outlook magazine
Immunophotonics is excited to be featured in Pharma Tech Outlook magazine in the Immunotherapy edition. Immunophotonics innovative approach could transform...
Read More
July 16, 2024
Authorization to Proceed Received on Immunophotonics’ INJECTABL-2 Clinical Trial
Immunophotonics is excited to announce that a leading academic medical center that combines high-quality complex patient care with innovative scientific...
Read More
June 12, 2024
Professor Wei Chen NAI Senior Member Induction
Lu Alleruzzo, CEO, Tomas Hode, PhD, CIO, and President, along with the Immunophotonics Team, extend their congratulations to Professor Wei...
Read More
June 5, 2024
Dr. Robert CG Martin II, M.D, PhD Presenting his IRE Data at the Central Surgical Association 81st Annual Meeting
Immunophotonics is excited to share that Dr. Robert CG Martin II, M.D, PhD, PACS, who serves as Principal Investigator and...
Read More
May 30, 2024
ASCO Chicago, May 31 – June 3, 2024
Immunophotonics co-founders Lu Alleruzzo (CEO) and Tomas Hode, PhD (CIO and President) will be in Chicago at the ASCO (American...
Read More
April 30, 2024
Immunophotonics Announces the Addition of Jacqueline Hess to its Advisory Board
Immunophotonics, Inc. is delighted to introduce Jacqueline Hess as the newest addition to our advisory board. Ms. Hess has over 25 years...
Read More
April 24, 2024
European Conference on Interventional Oncology (ECIO), April 28 – May 1, 2024
Tomas Hode, PhD, who serves as the Co-Founder, CIO, and President at Immunophotonics, Inc., will be attending the European Conference...
Read More
April 19, 2024
Swiss Biotech Day, April 22 – 23, 2024
Immunophotonics is thrilled to share that Dr. Theresa Visarius from Immunophotonics Switzerland (IPS Biopharma) will be attending the Swiss Biotech...
Read More